A player taking part in the inaugural, money-spinning Indian Premier League has failed a drugs test, the IPL commissioner Lalit Modi says.
"Two days ago the IPL received a letter from a Swiss agency, mandated by (world anti-doping body) WADA, which said one sample had tested positive," Modi told the www.cricinfo.com website.
"The IPL will follow set procedures from now on."
The tests were carried out under the supervision of WADA after the IPL, which ran from April 18-June 1, adopted the International Cricket Council's (ICC) code on doping.
Modi said that the identity of the player will now be matched with the sample before information is scrutinised for any pre-declared or prescribed drug.
If that is not the case then the 'B' sample will also be tested.
"This is just the procedure," added Modi.
"As of now we are at the first stage where one sample has tested positive. The issue is now with the IPL's medical committee. The identity of the player will matter only after we check on the pre-declared drugs."
The nature of the substance has not been disclosed.
World cricket's governing body, the ICC, said it was aware of the developments.
"The ICC is aware of an adverse analytical finding (AAF) from the recently-concluded Indian Premier League (IPL)," said a statement released from the ICC headquarters in Dubai.
"When an AAF arises, the World Anti-Doping Agency (WADA) accredited laboratory that has tested the sample sends a report to the commissioning body (IPL) and copies in WADA and the International Federation, in this case the ICC.
"As with any AAF that arises during a testing program organised by one of the ICC's members, it is the responsibility of that member, in this case the BCCI, to deal with the process in a timely and fair manner.
"The ICC is proud of its status as a WADA signatory and will be closely monitoring the situation to ensure the correct action is taken by the BCCI. The ICC retains a right of appeal if any penalty that may be imposed is inconsistent with the WADA Code."
